Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2303]
News [5292]
Articles [130]
Editorials [4]
Conferences [158]
elearning [13]
ASCO 2024: Osimertinib poised to change standard of care treatment for patients with locally advanced EGFR-mutated NSCLC
ASCO 2024: Osimertinib poised to change standard of care treatment for patients with locally advanced EGFR-mutated...
ASCO 2024: Lymphadenectomy may not be needed for patients with advanced ovarian cancer
ASCO 2024: Lymphadenectomy may not be needed for patients with advanced ovarian cancer
ASCO 2024: New study details longest progression-free survival ever reported in advanced NSCLC
ASCO 2024: New study details longest progression-free survival ever reported in advanced NSCLC
ASCO 2024: Asciminib may be safer, more effective treatment option for patients with newly diagnosed chronic myeloid leukaemia
ASCO 2024: Asciminib may be safer, more effective treatment option for patients with newly diagnosed chronic...
Access to targeted lung cancer drug durvalumab is cost-prohibitive globally
Access to targeted lung cancer drug durvalumab is cost-prohibitive globally
FDA grants accelerated approval to selpercatinib for pediatric patients two years and older with RET-altered metastatic thyroid cancer or solid tumours
FDA grants accelerated approval to selpercatinib for pediatric patients two years and older with RET-altered...
Gene cluster expression index and potential indications for targeted therapy and immunotherapy for lung cancers
Gene cluster expression index and potential indications for targeted therapy and immunotherapy for lung cancers
Treatment options for hepatocellular carcinoma using immunotherapy: present and future
Treatment options for hepatocellular carcinoma using immunotherapy: present and future
Inhibitory effect of miR-377 on prostate cancer cells
Inhibitory effect of miR-377 on prostate cancer cells
Scientists uncover promising treatment target for resistant brain cancer
Scientists uncover promising treatment target for resistant brain cancer

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation